Mohamed L. Salem - Concepedia

Author

Mohamed L. Salem

Tanta University ORCID

Also Known As

Hassan El Batae, I Ali, M L Salem, M Salem, M. E. Salem, M. L. SALEM, M. L. Salem, M. O. A. Salem, M. Salem, M.L Salem

231

Publications

6.7K

Citations

H-Index

101

Concepts

All Affiliations

Tanta University Medical University of South Carolina MUSC Hollings Cancer Center Kyushu University Tanta University Hospital

About

Mohamed L. Salem is an author at Tanta University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	34	3.5K
2	Allergy	5	5	281
3	Engineering	3	3	63
4	Health Sciences	3	3	80
5	Biomedical Engineering	2	2	50

Mohamed L. Salem

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy C. Marcela Díaz‐Montero, Mohamed L. Salem, Michael I. Nishimura, Cancer Immunology Immunotherapy Clinical Cancer StageTumor BiologyMedicineMetronomic TherapyImmunology	2008	1.2K
EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy Walid Osta, Yi‐An Chen, Kaidi Mikhitarian, Cancer Research Epcam Sirna TreatmentBreast OncologyImmunologyCell MigrationBreast Cancer	2004	561
Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection Mohamed L. Salem, Mohammad Sohrab Hossain International Journal of Immunopharmacology MedicineImmunologyBlack Seed OilMurine Cytomegalovirus InfectionPharmacology	2000	299
Defining the Antigen-Specific T-Cell Response to Vaccination and Poly(I:C)/TLR3 Signaling Mohamed L. Salem, Andre N. Kadima, David J. Cole, Journal of Immunotherapy Peptide VaccinationAdaptive Immune SystemT-regulatory CellImmunologyImmunologic Mechanism	2005	140
5-Aminoimidazole-4-Carboxamide Ribonucleoside: A Novel Immunomodulator with Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis Narender Nath, Shailendra Giri, Ratna Prasad, The Journal of Immunology	2005	135
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer Shikhar Mehrotra, Carolyn D. Britten, Steve Chin, Journal of Hematology & Oncology	2017	135
Protective effects of <i>Nigella sativa</i> oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide Faris Q Alenzi, Yousry El-Bolkiny, Mohamed L. Salem British Journal of Biomedical Science Pharmacological StudyMedicinePhysiologyHerb-drug InteractionNigella Sativa Seed	2010	119
Defining the Ability of Cyclophosphamide Preconditioning to Enhance the Antigen-specific CD8+ T-cell Response to Peptide Vaccination: Creation of a Beneficial Host Microenvironment Involving Type I IFNs and Myeloid Cells Mohamed L. Salem, Andre N. Kadima, Sabry El-Naggar, Journal of Immunotherapy Peptide VaccinationImmunologyImmunodominanceImmunologic MechanismAntigen Processing	2006	118
Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C) Mohamed L. Salem, C. Marcela Díaz‐Montero, Amir A. Al-Khami, The Journal of Immunology	2009	114
The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu Mohamed L. Salem, Sabry El-Naggar, Andre N. Kadima, Vaccine InflammationToll-like ReceptorsAdjuvant EffectsAutoimmune DiseaseAdaptive Immune System	2006	113

Page 1